Novel enterocin E20c purified from Enterococcus hirae 20c synergised with ß-lactams and ciprofloxacin against Salmonella enterica

BACKGROUND: An increasing rate of antibiotic resistance among Gram-negative bacterial pathogens has created an urgent need to discover novel therapeutic agents to combat infectious diseases. Use of bacteriocins as therapeutic agents has immense potential due to their high potency and mode of action...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Preeti, Rashid, Muzamil, Kaur, Sukhraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197179/
https://www.ncbi.nlm.nih.gov/pubmed/32366243
http://dx.doi.org/10.1186/s12934-020-01352-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197179/
https://www.ncbi.nlm.nih.gov/pubmed/32366243
http://dx.doi.org/10.1186/s12934-020-01352-x

Ejemplares similares